Safety and efficacy of convalescent plasma therapy in severely and critically ill patients with COVID-19: a systematic review with meta-analysis
More attention has been focused on the use of convalescent plasma (CP) for the treatment of SARS-CoV-2. The severely ill patients benefited more from CP than the critically ill patients. Adverse events were few and the effect of plasma on reducing viral load was apparent.
